A Survey to Evaluate the Cardiovascular Risk Status of Subjects With Pre-Diabetes in Hong Kong

Prediabetes Clinical Trial

— JADE-HK2  

Official title:

A Survey to Evaluate the Cardiovascular Risk Status of Subjects With Pre-Diabetes in Hong Kong: The Joint Asia Diabetes Evaluation (JADE) Program Sub-study 2 (JADE-HK2)

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT00786890
• Other study ID #: ADF-2008-2
• Status: Active, not recruiting
• Phase: N/A
• First received: November 5, 2008
• Last updated: August 21, 2015
• Start date: November 2008
• Est. completion date: December 2018

Study information

• Verified date: August 2015
• Source: Chinese University of Hong Kong
• Contact: n/a
• Is FDA regulated: No
• Health authority: Hong Kong: Joint CUHK-NTEC Clinical Research Ethics Committee
• Study type: Observational

Clinical Trial Summary

Hypothesis: A high cardiovascular risk is present in subjects with pre-diabetes in Hong Kong Chinese.

The investigators plan to assess Chinese subjects in Hong Kong who have pre-diabetes (impaired fasting glucose, IFG; or impaired glucose tolerance, IGT) based on oral glucose tolerance test (OGTT) on their cardiovascular risk status such as obesity, hypertension and lipid profile.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 3000
• Est. completion date: December 2018
• Est. primary completion date: December 2018
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Hong Kong Chinese with confirmed IFG or IGT by OGTT

Exclusion Criteria:

• Confirmed diabetic patients

Study Design

Observational Model: Case-Only, Time Perspective: Prospective

Related Conditions & MeSH terms

• Cardiovascular Risk Factors
• Glucose Intolerance
• Prediabetes
• Prediabetic State

Intervention

Other:
• observational, no intervention needed
observational, no intervention needed

Locations

Country	Name	City	State
China	Hong Kong Institute of Diabetes and Obesity	Hong Kong

Sponsors (1)

Lead Sponsor	Collaborator
Chinese University of Hong Kong

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Cardiovascular risk factors: anthroprometric parameters, blood pressure and lipid profiles		instant	No